507 related articles for article (PubMed ID: 20977545)
1. The diagnostic spectrum in patients with suspected chronic Lyme neuroborreliosis--the experience from one year of a university hospital's Lyme neuroborreliosis outpatients clinic.
Djukic M; Schmidt-Samoa C; Nau R; von Steinbüchel N; Eiffert H; Schmidt H
Eur J Neurol; 2011 Apr; 18(4):547-55. PubMed ID: 20977545
[TBL] [Abstract][Full Text] [Related]
2. Lyme neuroborreliosis: a treatable cause of acute ocular motor disturbances in children.
Correll MH; Datta N; Arvidsson HS; Melsom HA; Thielberg AK; Bjerager M; Brodsky MC; Saunte JP
Br J Ophthalmol; 2015 Oct; 99(10):1401-4. PubMed ID: 25868792
[TBL] [Abstract][Full Text] [Related]
3. Application of multiplexing technology to the analysis of the intrathecally released immunoglobulins against B. burgdorferi antigens in neuroborreliosis.
Zajkowska J; Lelental N; Kulakowska A; Mroczko B; Pancewicz S; Bucki R; Kornhuber J; Lewczuk P
Immunol Lett; 2015 Nov; 168(1):58-63. PubMed ID: 26210581
[TBL] [Abstract][Full Text] [Related]
4. Clinical usefulness of intrathecal antibody testing in acute Lyme neuroborreliosis.
Ljøstad U; Skarpaas T; Mygland A
Eur J Neurol; 2007 Aug; 14(8):873-6. PubMed ID: 17662007
[TBL] [Abstract][Full Text] [Related]
5. Clinical aspects of neuroborreliosis and post-Lyme disease syndrome in adult patients.
Pfister HW; Rupprecht TA
Int J Med Microbiol; 2006 May; 296 Suppl 40():11-6. PubMed ID: 16524775
[TBL] [Abstract][Full Text] [Related]
6. [Clinical forms of neuroborreliosis among hospitalized patients in the years 2000-2005].
Czupryna P; Kuśmierczyk J; Zajkowska JM; Ciemerych M; Kondrusik M; Ciemerych A; Pancewicz SA
Pol Merkur Lekarski; 2007 Aug; 23(134):103-6. PubMed ID: 18044338
[TBL] [Abstract][Full Text] [Related]
7. Disagreement between the results from three commercial tests for the detection of Borrelia-specific serum antibodies in the Netherlands associated with antibiotic treatment for Lyme borreliosis: a retrospective study.
van Gorkom T; Kremer K; Voet W; Notermans DW; Vlaminckx BJM; Sankatsing SUC; Thijsen SFT
Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2137-2146. PubMed ID: 28748396
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic performance of cerebrospinal fluid chemokine CXCL13 and antibodies to the C6-peptide in Lyme neuroborreliosis.
Tjernberg I; Henningsson AJ; Eliasson I; Forsberg P; Ernerudh J
J Infect; 2011 Feb; 62(2):149-58. PubMed ID: 21087629
[TBL] [Abstract][Full Text] [Related]
9. Pediatric Lyme Neuroborreliosis: Different clinical presentations of the same agent; Single center experience.
Celik T; Celik U; Kömür M; Tolunay O; Yildizdas RD; Yagci-Kupeli B; Kücük F; Eroglu İ
Neuro Endocrinol Lett; 2016; 37(2):107-13. PubMed ID: 27179572
[TBL] [Abstract][Full Text] [Related]
10. CSF B--lymphocyte chemoattractant (CXCL13) in the early diagnosis of acute Lyme neuroborreliosis.
Ljøstad U; Mygland A
J Neurol; 2008 May; 255(5):732-7. PubMed ID: 18344056
[TBL] [Abstract][Full Text] [Related]
11. Lyme neuroborreliosis in children: a prospective study of clinical features, prognosis, and outcome.
Skogman BH; Croner S; Nordwall M; Eknefelt M; Ernerudh J; Forsberg P
Pediatr Infect Dis J; 2008 Dec; 27(12):1089-94. PubMed ID: 19008771
[TBL] [Abstract][Full Text] [Related]
12. Borrelia antibodies in children evaluated for Lyme neuroborreliosis.
Bennet R; Lindgren V; Zweygberg Wirgart B
Infection; 2008 Oct; 36(5):463-6. PubMed ID: 18791841
[TBL] [Abstract][Full Text] [Related]
13. Lyme meningoradiculitis: prospective evaluation of biological diagnosis methods.
Roux F; Boyer E; Jaulhac B; Dernis E; Closs-Prophette F; Puéchal X
Eur J Clin Microbiol Infect Dis; 2007 Oct; 26(10):685-93. PubMed ID: 17629757
[TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics of childhood Lyme neuroborreliosis in an endemic area of northern Europe.
Øymar K; Tveitnes D
Scand J Infect Dis; 2009; 41(2):88-94. PubMed ID: 19065451
[TBL] [Abstract][Full Text] [Related]
15. [Acquired nystagmus in a 12-year-old boy as initial presentation of Lyme disease].
Samimi S; Salah S; Bonicel P
J Fr Ophtalmol; 2011 May; 34(5):325.e1-3. PubMed ID: 21496946
[TBL] [Abstract][Full Text] [Related]
16. EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis.
Mygland A; Ljøstad U; Fingerle V; Rupprecht T; Schmutzhard E; Steiner I;
Eur J Neurol; 2010 Jan; 17(1):8-16, e1-4. PubMed ID: 19930447
[TBL] [Abstract][Full Text] [Related]
17. Does more favourable handling of the cerebrospinal fluid increase the diagnostic sensitivity of Borrelia burgdorferi sensu lato-specific PCR in Lyme neuroborreliosis?
Forselv KJN; Lorentzen ÅR; Ljøstad U; Mygland Å; Eikeland R; Kjelland V; Noraas S; Quarsten H
Infect Dis (Lond); 2018 Apr; 50(4):297-302. PubMed ID: 29125008
[TBL] [Abstract][Full Text] [Related]
18. Lyme neuroborreliosis in cases of non-specific neurological symptoms.
Roaldsnes E; Eikeland R; Berild D
Tidsskr Nor Laegeforen; 2017 Jan; 137(2):101-104. PubMed ID: 28127071
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid findings in patients with symptoms suggesting chronic Lyme borreliosis.
Ogrinc K; Lotric-Furlan S; Maraspin V; Cimperman J; Ruzić-Sabljić E; Strle F
Wien Klin Wochenschr; 2002 Jul; 114(13-14):535-8. PubMed ID: 12422597
[TBL] [Abstract][Full Text] [Related]
20. Lyme neuroborreliosis: improvements of the laboratory diagnosis and a survey of epidemiological and clinical features in Denmark 1985-1990.
Hansen K
Acta Neurol Scand Suppl; 1994; 151():1-44. PubMed ID: 8165888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]